Data Management

A high performing team of global data management experts.

Everyone on the MMS team has been so collaborative and responsive. It is rare to have such a seamless experience.
Biometrics Leader
Large Pharmaceutical Partner

Driven by quality, the experts at MMS approach every biometrics deliverable as a top priority, no matter the size or scope of the project. You and your team can expect in-depth, thoughtful conversations with team members, knowing that they are thought leaders, invited speakers, and change makers in industry groups across the globe.

Certified in multiple industry esteemed EDC platforms, allowing for flexible approach to database builds and efficiencies to tailor to Sponsor requirements as projects progress.

Data Management services at MMS are designed to streamline  the process of design, collection, reconciliation, and review of clinical research data. Our clinical data specialists manage all aspects of the data while you stay in complete control — with continuous access to data and total transparency to study progress.

Working with MMS brings:

  • An experienced, award-winning team to manage studies across a variety of industry leading EDC platforms, including accreditations to build in Rave, Zelta, and Medrio
  • Expertise to recommend and deploy cutting-edge “e” technologies, including eCOA (eClinRO and ePRO), eDiary, and eConsent 
  • A wide range of therapeutic area expertise
  • Proven processes to begin clinical studies faster, with accurate, clean results that exceed expectations
  • Near real-time access to clean clinical data, including added visibility via Datacise technology
  • A single point of contact, reducing communication burden and increasing historical knowledge

MMS Clinical Data Managers provide: 

  • Expert knowledge on EDC technology and surrounding processes
  • Clean, reproducible fit-for-analysis data, with cross functional support from the entire biometrics team
  • Lead Data Managers that rise to the challenge of aggressive study timelines
  • Knowledge transfer and industry-leading CRO retention rates increase efficiencies to propel study conduct to the finish line while ensuring data integrity

Suggested For You

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer